R. Sampliner

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R. Sampliner, Richard E Sampliner, Richarde Sampliner, Richard E. Sampliner, R. E. Sampliner, R E Sampliner, Richard Sampliner, R Sampliner
Publication record
390 papers · 25,569 citations · H-index 76

PAPERS

Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
202016 citationsauthor #9
Asymptomatic Parotid Enlargement in Pima Indians
20200 citationsauthor #2
Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
201925 citationsauthor #15
Lower Annual Rate of Progression of Short‐Segment vs Long‐Segment Barrett's Esophagus to Esophageal Adenocarcinoma
201965 citationsauthor #14
Tu1132 - Barrett's Esophagus Patients with Non-Dysplastic Visible Mucosal Lesions have a Higher Risk of Neoplastic Progression: Results from a Large Multi-Center Consortium
20180 citationsauthor #14
9 - Barrett's Esophagus International Consortium Study: Detection of Post-Endoscopy Neoplastic Progression in Patients Undergoing Surveillance
20180 citationsauthor #8
Mo1006 - A Detailed Analysis of the Characteristics and Histology of Visible Mucosal Abnormalities in Patients Undergoing Surveillance Endoscopy for Barrett's Esophagus (BE): Results from a Multicenter Cohort
20180 citationsauthor #17
Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
2017109 citationsauthor #10
Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
2017118 citationsauthor #10
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett’s Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium
201751 citationsauthor #27
Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
201772 citationsauthor #8
Defining the Rates of Missed and Interval High-Grade Lesions in Patients With Barrettʼs Esophagus: Results From a Large Multicenter Study: 308
20170 citationsauthor #8
Increased Recognition of HGD/EAC at Index Endoscopy Over the Past 2 Decades: Data from a Multi-Center U.S. Consortium
20170 citationsauthor #17
Neoplastic Progression in Patients with Short Segment Barrett's Esophagus: Long-Term Follow-up of Over a 1000 Patients in a Multi-Center Consortium
20170 citationsauthor #14
Sa1255 Low Risk of Neoplastic Progression of Barrett's Esophagus in Women: Results From a Large Multi-Center Consortium
20160 citationsauthor #9
839 Should We Discontinue Surveillance in Patients With Irregular z line (<1 cm Barrett's Esophagus): Results from a Large, Multicenter, Cohort Study
20160 citationsauthor #8
Development and Validation of a Prediction Model Associated with Neoplastic Progression of Barrettʼs Esophagus (BE): Data from a Multi-Center Prospective Cohort: 426
20161 citationsauthor #12
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
201648 citationsauthor #27
BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia
2015166 citationsauthor #38
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia
20157 citationsauthor #38
Clinical outcomes in patients with a diagnosis of “indefinite for dysplasia” in Barrett’s esophagus: a multicenter cohort study
201523 citationsauthor #19
Esophageal cancer and barrett's esophagus: Sharma/Esophageal cancer and barrett's esophagus
20150 citationsauthor #2
Update on Screening, Surveillance, and Treatment
20150 citationsauthor #2
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (vol 110, pg 662, 2015)
20150 citationsauthor #38
Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort
201515 citationsauthor #9
Sa1850 Should We Continue to Follow Patients With <1 CM Barrett's Esophagus (Irregular Z Line): Results From a Large, Multicenter, Cohort Study
20140 citationsauthor #16
Tu1079 Adherence to Surveillance Guidelines in Patients With Barrett's Esophagus (BE): Analysis From a Large Multicenter Cohort Study
20140 citationsauthor #15
710 Proton Pump Inhibitor Use but Not Statin Use Is Associated With Decreased Risk for High-grade Dysplasia and Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Results From a Large, Multicenter Cohort Study
20143 citationsauthor #16
Mo1894 Barrett's Esophagus Length Is Determined At the Time of Initial Development and Does Not Change Over Time: Results From a Large Multicenter Cohort
20130 citationsauthor #10
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
2013134 citationsauthor #17
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
201387 citationsauthor #17
Tu1102 Are Clinical Outcomes in Indefinite for Dysplasia (IND) Any Different From Low Grade Dysplasia (LGD) in Patients With Barrett's Esophagus (BE)? Results From a Large Multicenter Cohort Study
20120 citationsauthor #17
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
201246 citationsauthor #4
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.
2012406 citationsauthor #70
Barrett’s Oesophagus
201219 citationsauthor #2
962 Decreasing Rates of Esophageal Adenocarcinoma (EAC) in Patients With Persistent Non Dysplastic Barrett's Esophagus (NDBE): Results From a Large Multicenter Cohort
20124 citationsauthor #16
Agreement Among Expert Gastrointestinal Pathologists for Low-Grade Dysplasia (LGD) in Barrett's Esophagus (BE) and Implications for Progression: Results From a Large, Multicenter Cohort Study
20115 citationsauthor #13
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
2011243 citationsauthor #21
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
2011256 citationsauthor #23
Is the Extent of Low-Grade Dysplasia (LGD) in Barrett's Esophagus (BE) a Risk Factor for the Development of Esophageal Adenocarcinoma (EAC): Results From a Large, Multicenter Cohort Study
20112 citationsauthor #16
CLINICAL—ALIMENTARY TRACT Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus
20111 citationsauthor #22
Management of nondysplastic barrett esophagus with ablation therapy.
20115 citationsauthor #1
Relationship Between Barrett's Esophagus (BE) Length and the Risk of High Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non Dysplastic Barrett's Esophagus Results From a Large Multicenter Cohort
20119 citationsauthor #13
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
2011477 citationsauthor #3
M1099 Do Numeracy Skills Impact Cancer Risk Perception in Barrett's Esophagus?
20100 citationsauthor #5
S1056 The Prevalence of Dysplasia is Increasing in Patients With Newly Diagnosed Barrett's Esophagus (BE): Secular Trends From a Large, Multicenter, Cohort Study
20102 citationsauthor #19
Print and Media Review
20100 citationsauthor #1
Chapter 7 – Barrett's Esophagus
20100 citationsauthor #1
475c Low Risk of Developing Dysplasia and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter, Cohort Study
201010 citationsauthor #21
W1051 Adherence to Surveillance Interval Guidelines in Barrett's Esophagus (BE): Analysis From a Large Multicenter Cohort Study
20100 citationsauthor #20
Surveillance of Barrett's esophagus
20100 citationsauthor #1
M1107 Durability of Ablative Therapies in Barrett's Esophagus (BE): Long Term Results of a Randomized Controlled Trial (RCT) of Ablation With Argon Plasma Coagulation (APC) and Multipolar Electrocoagulation (MPEC)
20105 citationsauthor #12
M1104 Predicting High-Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter Cohort Study
20104 citationsauthor #19
1035 The Use of FISH in a Multi-Center Blinded Study to Predict Development of Neoplasia in Barrett's Esophagus
20090 citationsauthor #16
Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma
200930 citationsauthor #8
1039 How Durable Is the Reversion to Neosquamous Epithelium in Subjects Undergoing Radiofrequency Ablation for Dysplastic Barrett's Esophagus? Two Year Follow-Up of the AIM-Dysplasia Randomized Sham-Controlled Trial
20091 citationsauthor #5
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
2009227 citationsauthor #29
A surgical experience suggesting the threshold for endoscopic therapy.
20090 citationsauthor #1
Comprar Endoscopic Therapy for Barrett's Esophagus | Sampliner, Richard E. | 9781603274449 | Springer
20090 citationsauthor #1
Radiofrequency ablation in Barrett's esophagus with dysplasia.
20091,318 citationsauthor #5
Medical treatment of Barrett's esophagus: can it prevent cancer?
20094 citationsauthor #1
Endoscopic therapy for Barrett's esophagus.
20098 citationsauthor #1
197 A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
20090 citationsauthor #24
T1879 Low-Grade Dysplasia (LGD) Is a Poor Marker for Cancer Progression in Patients with Barrett's Esophagus (BE): Preliminary Results from a Large, Multi-Center, Cohort Study
20093 citationsauthor #3
Management of Nondysplastic Barrett's Esophagus: Where Are We Now?
200928 citationsauthor #3
Medication usage and the risk of neoplasia in patients with Barrett's esophagus.
2009155 citationsauthor #6
Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach
20095 citationsauthor #2
High Prevalence of Metabolic Syndrome in Patients with Barrett's Esophagus: A Multi-Center, Registry Study
20091 citationsauthor #2
Musculoskeletal Injuries Among Gastroenterologists; Is Colonoscopy The Culprit?: 1350
20090 citationsauthor #7
213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial
200855 citationsauthor #6
An important consensus statement on the management of gastroesophageal reflux disease for the largest population in the world
20082 citationsauthor #1
The Prevalence of Barrett's Esophagus in Veteran Patients with and Without GERD Symptoms Undergoing Outpatient Colonoscopy
20084 citationsauthor #7
Updated Guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus (American Journal of Gastroenterology (March 2008) 103: 3 (788))
20081 citationsauthor #19
M1021 Thermal Ablation of Barrett's Esophagus: A 6 year Follow-Up
20081 citationsauthor #2
MEDICAL THERAPY FOR BARRETT'S ESOPHAGUS
20080 citationsauthor #1
The Diagnostic Accuracy of Esophageal Capsule Endoscopy in Patients With Gastroesophageal Reflux Disease and Barrett's Esophagus: A Blinded, Prospective Study
200889 citationsauthor #9
Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial
2008107 citationsauthor #7
Finding the needle in the haystack: identifying the high-risk "premalignant" gastric lesion.
20080 citationsauthor #1
Clinical evaluation of a confocal microendoscope system for imaging the ovary
20086 citationsauthor #4
Clinical and Endoscopic Characteristics of a Large Cohort of Barrett's Esophagus (BE) Patients with Low and High-Grade Dysplasia
20080 citationsauthor #2
Faculty Opinions recommendation of Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
20081 citationsauthor #1
M1995 InterSPORE/EDRN Barrett's Esophagus (BE) Study: Interim Report of a Multicenter Case-Control Study of Progressors to High-Grade Dysplasia/Adenocarcinoma vs. Nonprogressors
20082 citationsauthor #1
W1876 Are Biopsies After Ablation for Dysplastic Barrett's Esophagus of Adequate Depth to Detect Glandular Mucosa Beneath the Neosquamous Epithelium? - Comparative Histopathological Outcomes from a Randomized, Sham-Controlled Trial (Aim Dysplasia Trial)
20084 citationsauthor #3
Comprar Gastrointestinal Oncology: A Critical Multidisciplinary Approach | Yuman Fong | 9781405127837 | Blackwell Publishing
20080 citationsauthor #3
Subsquamous Intestinal Metaplasia Is a Common Finding in Ablation-Naïve Patients with Dysplastic Barrett's Esophagus, and Significantly Decreases in Prevalence After Radiofrequency Ablation
20082 citationsauthor #9
M1957 Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma
20081 citationsauthor #8
Screening for Barrett's Esophagus: Targeting High Risk Patients
20070 citationsauthor #1
Faculty Opinions recommendation of Appropriateness of upper-GI endoscopy: an Italian survey on behalf of the Italian Society of Digestive Endoscopy.
20070 citationsauthor #1
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma
200760 citationsauthor #7
Confocal microendoscope for use in a clinical setting
200713 citationsauthor #5
Is Their a Preferred Location of Intestinal Metaplasia in Barrett's Esophagus?
20070 citationsauthor #4
Faculty Opinions recommendation of NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
20070 citationsauthor #1
Risk for cancer in Barrett’s esophagus: Medical versus surgical therapy
20071 citationsauthor #2
Detection of Intestinal Metaplasia in Barrett's Esophagus
20075 citationsauthor #7
Endoscopic therapy for barrett's high-grade dysplasia: entering the therapeutic arena.
20072 citationsauthor #1
Interobserver Agreement for the Detection of Barrett's Esophagus (BE) with Esophageal Capsule Endoscopy (ECE)
20073 citationsauthor #4
Proton Pump Inhibitor and Nonsteroidal Anti-Inflammatory Use and the Development of Neoplasia in Barrettʼs Esophagus: 11
20070 citationsauthor #6
Faculty Opinions recommendation of Low-grade dysplasia in Barrett's esophagus has a high risk of progression.
20070 citationsauthor #1
Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies
2007244 citationsauthor #7
Five-year colon surveillance after screening colonoscopy.
2007442 citationsauthor #19

TIMELINE

1947 0 citations

1970 379 citations

1973 0 citations

1974 174 citations

1975 5 citations

1977 3 citations

1978 3 citations

1979 139 citations

1980 22 citations

1981 39 citations

1982 316 citations

1983 8 citations

1984 73 citations

1985 16 citations

1986 54 citations

1987 184 citations

1988 60 citations

1989 261 citations

1990 1,372 citations

1991 499 citations

1992 1,591 citations

1993 1,704 citations

1994 560 citations

1995 89 citations

1996 473 citations

1997 1,215 citations

1998 3,525 citations

1999 1,002 citations

2000 1,449 citations

2001 804 citations

2002 716 citations

2003 864 citations

2004 1,094 citations

2005 366 citations

2006 918 citations

2007 856 citations

2008 275 citations

2009 1,780 citations

2010 21 citations

2011 998 citations

2012 475 citations

2013 221 citations

2014 3 citations

2015 211 citations

2016 49 citations

2017 350 citations

2018 0 citations

2019 90 citations

2020 16 citations

Unknown 3 citations

R. Sampliner

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT